GlassScriptPhysician profile
Phillip T Gullic
NPI 1285606020
$5,168.57
in general payments reported to CMS, 2019-2025
44 companies · $658 in 2025
The $658 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $635 · 2020: $554 · 2021: $1,055 · 2022: $934 · 2023: $764 · 2024: $568 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,800 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,800.47 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $792.68 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $441.26 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $366.17 | 2019-2025 | |
| Astellas Pharma US INC | $334.92 | 2023-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $321.32 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $309.61 | 2019-2024 | |
| Organon LLC | $255.81 | 2021-2025 | Nexplanon, Jada System |
| Exeltis, USA INC. | $225.81 | 2020-2025 | Slynd |
| Avion Pharmaceuticals | $174.55 | 2020-2022 | |
| Allergan, INC. | $161.82 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $153.69 | 2019-2022 | |
| Minerva Surgical, INC | $149.90 | 2019-2022 | |
| Shield Therapeutics INC | $140.60 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $116.05 | 2019-2021 | |
| Baxter Healthcare | $106.00 | 2020 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $104.15 | 2021-2023 | Phexxi |
| Therapeuticsmd, INC. | $94.61 | 2019-2022 | |
| Duchesnay USA Incorporated | $79.26 | 2019 | |
| Hologic Sales and Service, LLC | $70.97 | 2019-2025 | Aptima |
| Amgen INC. | $66.43 | 2019-2021 | |
| Smith+Nephew, INC. | $54.47 | 2021-2025 | Stravix |
| Medtronic, INC. | $52.49 | 2022-2023 | Interstim |
| Sumitomo Pharma America, INC. | $52.00 | 2023-2025 | Gemtesa, Myfembree |
| Millicent US INC | $47.68 | 2025 | Intrarosa, Femlyv |
| Glaxosmithkline, LLC. | $42.64 | 2020-2021 | |
| Aspira Women'S Health INC | $42.23 | 2021 | |
| Davol INC. | $42.00 | 2023 | Arista Ah Flexitip |
| Urovant Sciences INC | $40.01 | 2021-2022 | |
| Coloplast Corp | $38.41 | 2020-2024 | |
| Becton, Dickinson and Company | $37.32 | 2019 | |
| Innovation Technologies INC | $32.32 | 2025 | Irrisept |
| Lupin INC. | $28.68 | 2019-2020 | |
| Lilly USA, LLC | $27.25 | 2022-2023 | Emgality, Reyvow |
| Olympus America INC. | $23.02 | 2019 | |
| Mimedx Group, INC. | $18.63 | 2024 | |
| Medline Industries LP | $17.91 | 2022 | |
| Ethicon US, LLC | $16.65 | 2020 | |
| Dexcom, INC. | $16.06 | 2025 | Dexcom G6 Transmitter |
| Baudax Bio INC. | $15.89 | 2020 | |
| Meditrina | $13.62 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.48 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.47 | 2022 | |
| Agile Therapeutics, INC. | $11.83 | 2021 | |
| Kinex Medical Company LLC | $4.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Gullic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.